These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1330001

  • 21. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ, Austin VN, Zimmer SG, Fisher PB.
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines.
    Bussolino F, De Rossi M, Sica A, Colotta F, Wang JM, Bocchietto E, Padura IM, Bosia A, DeJana E, Mantovani A.
    J Immunol; 1991 Oct 01; 147(7):2122-9. PubMed ID: 1918946
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F.
    Melanoma Res; 1997 Aug 01; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [Abstract] [Full Text] [Related]

  • 27. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine.
    Su ZZ, Shen R, O'Brian CA, Fisher PB.
    Oncogene; 1994 Apr 01; 9(4):1123-32. PubMed ID: 7510863
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tumorigenicity of revertant from an SV40-transformed line.
    Steinberg BM, Rifkin D, Shin S, Boone C, Pollack R.
    J Supramol Struct; 1979 Apr 01; 11(4):539-46. PubMed ID: 232523
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
    Mäntyjärvi R, Sarkkinen H, Parkkinen S, Laatikainen A, Ryhänen A, Syrjänen K.
    Intervirology; 1988 Apr 01; 29(6):311-9. PubMed ID: 2852654
    [Abstract] [Full Text] [Related]

  • 34. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells.
    Himelstein BP, Canete-Soler R, Bernhard EJ, Muschel RJ.
    J Cell Sci; 1994 Feb 01; 107 ( Pt 2)():477-86. PubMed ID: 8207074
    [Abstract] [Full Text] [Related]

  • 35. Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.
    Laatikainen A, Sarkkinen H, Syrjänen K, Mäntyjärvi R.
    APMIS; 1990 Oct 01; 98(10):909-15. PubMed ID: 2173935
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.
    Laatikainen A, Karjalainen H, Jägerroos H, Sarkkinen H, Mäntyjärvi R.
    Cancer Immunol Immunother; 1990 Oct 01; 31(3):164-8. PubMed ID: 2159847
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The in vivo enhancement of IL-1alpha receptor expression on polyoma virus transformed tumor derived cells.
    Arons E, Zusman T, Ran M.
    Int J Oncol; 1998 Jun 01; 12(6):1379-83. PubMed ID: 9592203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.